Literature DB >> 8587256

Factors influencing serum levels and peritoneal clearances of low molecular weight proteins in continuous ambulatory peritoneal dialysis.

A Kabanda1, E Goffin, A Bernard, R Lauwerys, C van Ypersele de Strihou.   

Abstract

To identify the factors influencing the serum concentrations and the peritoneal clearances of low molecular weight proteins (LMWP), fourteen patients on continuous ambulatory peritoneal dialysis (CAPD) for 1 to 57 (mean 9.4) months were examined. LMWP [Beta 2-microglobulin (Beta 2m, molecular wt 11.8 kD), cystatin C (cyst C, molecular wt 13.2 kD), Clara cell protein (CC16, molecular wt 15.8 kD), retinol-binding protein (RBP, molecular wt 21 kD) and alpha 1-microglobulin (Alpha 1m, molecular wt 33 kD)] and high molecular weight proteins (HMWP) [albumin (Alb, molecular wt 66 kD), immunoglobulins (IgG, molecular wt 170 kD and IgM, molecular wt 600 kD) and alpha 2-macroglobulin (Alpha 2m, molecular wt 718 kD)] were determined by latex immunoassay in the serum and dialysate collected during the peritoneal equilibration test (PET) with 2.27% dextrose (N = 14), and in dialysate from 56 standard exchanges, performed the day preceding PET, with 1.36% (N = 21), 2.27% (N = 23) and 3.86% (N = 12) dextrose. Determinants of serum concentrations and transperitoneal clearances of the proteins were traced by stepwise regression analysis using as possible contributors age, sex, residual diuresis, duration of the therapy (for serum concentrations), molecular radius of the protein and peritoneal membrane characteristics (for peritoneal clearances). LMWP serum concentrations were markedly increased whereas serum concentrations of HMWP were within the normal range. Residual diuresis, age and duration of dialysis emerged as significant determinants of serum concentration of some proteins, whereas transperitoneal clearance was dependent mainly on the size of the protein and, only for HMWP, on the dwell time. Residual diuresis was inversely related to the serum concentrations of four LMWP. Age was negatively correlated to the serum concentrations of beta 2m, CC16 and RBP. RBP and Alb were the only proteins whose serum concentration significantly decreased with time on CAPD. The relationship between peritoneal clearance and M(r) shows two slopes suggesting the existence of two populations of pores in the peritoneal capillary wall: small pores of about 20 to 25 A radius and large pores exceeding 100 A radius. A long dialysis cycle is associated with significant loss of HMWP only. Daily peritoneal protein losses, in mg (mean +/- SD), were as follows: Beta 2m 43.4 +/- 4.5; cyst C 9.6 +/- 1.8; CC16 1.8 +/- 0.3; RBP 58.9 +/- 11.1; Alpha 1m 149.5 +/- 15.7; Alb 6570 +/- 530; IgG 750 +/- 111; IgM 46.4 +/- 14.9; and alpha 2m 67.0 +/- 12.7. In conclusion, LMWP concentrations in the serum of patients on CAPD were markedly increased and influenced mainly by patient-related factors (residual diuresis and age). Serum albumin and RBP declined with the duration of dialysis. Peritoneal protein loss was determined by the size of the protein and, for large proteins, by the dwell time. The peritoneum behaves as a membrane with at least two populations of pores.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8587256     DOI: 10.1038/ki.1995.495

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  15 in total

1.  The relationship between the soluble Klotho protein and the residual renal function among peritoneal dialysis patients.

Authors:  Tetsu Akimoto; Kazuhiro Shiizaki; Taro Sugase; Yuko Watanabe; Hiromichi Yoshizawa; Naoko Otani; Akihiko Numata; Eri Takeshima; Tomoyuki Yamazaki; Takuya Miki; Chiharu Ito; Johanne V Pastor; Yoshitaka Iwazu; Osamu Saito; Shigeaki Muto; Makoto Kuro-o; Eiji Kusano
Journal:  Clin Exp Nephrol       Date:  2012-02-18       Impact factor: 2.801

2.  Purification and characterization of high molecular mass and low molecular mass cystatin from goat brain.

Authors:  Sadia Sumbul; Bilqees Bano
Journal:  Neurochem Res       Date:  2006-10-25       Impact factor: 3.996

3.  Preservation of Residual Kidney Function and Urine Volume in Patients on Dialysis.

Authors:  Raymond T Krediet
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-22       Impact factor: 8.237

4.  Estimating residual kidney function in dialysis patients without urine collection.

Authors:  Tariq Shafi; Wieneke M Michels; Andrew S Levey; Lesley A Inker; Friedo W Dekker; Raymond T Krediet; Tiny Hoekstra; George J Schwartz; John H Eckfeldt; Josef Coresh
Journal:  Kidney Int       Date:  2016-01-21       Impact factor: 10.612

5.  Mechanisms of Crystalloid versus Colloid Osmosis across the Peritoneal Membrane.

Authors:  Johann Morelle; Amadou Sow; Charles-André Fustin; Catherine Fillée; Elvia Garcia-Lopez; Bengt Lindholm; Eric Goffin; Fréderic Vandemaele; Bengt Rippe; Carl M Öberg; Olivier Devuyst
Journal:  J Am Soc Nephrol       Date:  2018-05-29       Impact factor: 10.121

6.  Serum Cystatin C Does Not Predict Mortality or Treatment Failure in Peritoneal Dialysis: A Prospective Study.

Authors:  Michael P Delaney; Paul E Stevens; Helen J Witham; Caroline Judge; Gillian L Eaglestone; Joanne L Carter; Paul Bassett; Edmund J Lamb
Journal:  Perit Dial Int       Date:  2014-09-02       Impact factor: 1.756

7.  Comparison of guanidine hydrochloride (GdnHCl) and urea denaturation on inactivation and unfolding of human placental cystatin (HPC).

Authors:  Fouzia Rashid; Sandeep Sharma; Bilqees Bano
Journal:  Protein J       Date:  2005-07       Impact factor: 2.371

8.  Neutrophil gelatinase-associated lipocalin in peritoneal effluent: evaluation in peritoneal dialysis patients in basal condition.

Authors:  Francesca Martino; Ilenia Filippi; Davide Giavarina; Gianpaolo Amici; Massimo de Cal; Manish Kaushik; Maria Pia Rodighiero; Carlo Crepaldi; Claudio Ronco
Journal:  Perit Dial Int       Date:  2013-01-02       Impact factor: 1.756

Review 9.  Cystatin C in aging and in Alzheimer's disease.

Authors:  Paul M Mathews; Efrat Levy
Journal:  Ageing Res Rev       Date:  2016-06-19       Impact factor: 10.895

Review 10.  Protective mechanisms by cystatin C in neurodegenerative diseases.

Authors:  Sebastien Gauthier; Gurjinder Kaur; Weiqian Mi; Belen Tizon; Efrat Levy
Journal:  Front Biosci (Schol Ed)       Date:  2011-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.